this is all that was posted on Fidelity but I'll see if I can find more info. it was today's news. i think CELG is bringing down the sector this morning however so upgrade is being overlooked
This is pretty decisive move we are seeing.
Gotta have a few good biotechs, industrials to ward against this consistent stock price manipulation.
This can't hurt the IBB and BIB. ETF's rule the biotechs. Hopefully we can get some respect after VRX slaughtered. GILD also on a good roll. CELG over 118 in pre-market. Should be much higher.
The whole sector has been under fire and plagued by short selling. BIIB and ISRG both reported stellar results. GILD, AMGN, CELG on board to report yet. The Street instead focuses on VRX which has brought down the whole sector this morning. VRX is getting slammed! Its about ETF's bundling in the baskets, the good and the bad. This is not GILD specific whatsoever.
Dude on CNBC basically just said the same thing. The said worker bees at MS are great but their management is terrible. Also slammed them for not giving us a heads up! They saw this coming and did nothing whatsoever to let the investment community know. This smells of a "class action" imo!
This is very irresponsible to wait until an earnings release and miss your target by this extreme! Shame shame on MS management!
Maybe that was the bottom. Certainly hope so.